Status:
COMPLETED
A Study of DPP-IV Inhibitor in Patients With Type 2 Diabetes
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Diabetes Mellitus Type 2
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This study will assess the efficacy, safety and tolerability of DPP-IV Inhibitor in patients with type 2 diabetes receiving a stable dose of metformin. The anticipated time on study treatment is 3-12 ...
Eligibility Criteria
Inclusion
- adult patients 18-75 years of age;
- type 2 diabetes;
- stable metformin therapy for \>=3 months before screening.
Exclusion
- women who are pregnant, breast-feeding, or not using an adequate contraceptive method;
- type 1 diabetes;
- any anti-hyperglycemic medication other than metformin in the last 3 months.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT00111631
Start Date
May 1 2005
End Date
October 1 2006
Last Update
November 2 2016
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Concord, California, United States, 94520
2
Salinas, California, United States, 93901
3
San Diego, California, United States, 92161
4
Boulder, Colorado, United States, 80304